InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Victoria Hull. Director active across 1 company, notably Hikma Pharmaceuticals PLC. In total, 3 reports have been recorded. Activity tracked since 8 April 2025. The latest transaction was disclosed on 27 April 2026 (Purchase). Regulator: RNS (LSE). All data is openly available.
3 of 3 declarations